| Intervention | Curcumin |
| Suggested dose | 500–1,000 mg po bid (of absorption-enhanced curcumin) |
| Mechanism(s) of action against non-COVID-19 viruses | Favorably modulate viral-induced pathological cellular processes: |
| Outcomes data supporting their mitigating effects on illness from other viral strains | No data available |
| Strength of evidence | Conditional |
| Risk of harm22-27 | Mimimal |